查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球数位药房市场：按药物类型、产品类型、平台、商业模式 - 区域展望、竞争策略、分部预测（-2030 年）
市场调查报告书
商品编码
1110905

全球数位药房市场：按药物类型、产品类型、平台、商业模式 - 区域展望、竞争策略、分部预测（-2030 年）

Global Digital Pharmacy Market- By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 238 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

到 2030 年，全球数位药房市场规模预计将增长 16.8%，达到 3342.5 亿美元。

消费者对在线购买药品的需求不断上升、市场整合和合作伙伴关係以及人口老龄化的加剧正在推动数位药房市场的增长。然而，越来越多的药店和越来越多的依赖药剂师提供治疗支持的患者正在抑制市场的增长。

本报告研究和分析全球数位药房市场，提供包括市场动态、市场分析和公司概况在内的系统信息。

内容

第一章介绍

  • 调查范围
  • 细分市场分析

第二章研究方法

  • 调查数据源
    • 辅助数据
    • 主要数据
    • SPER 内部数据库
    • KOL 见解
  • 市场规模估计
    • 自上而下和自下而上的方法
  • 数据三角剖分

第 3 章执行摘要

第 4 章市场动态

  • 分析驱动因素、制约因素、机遇和挑战
    • 驱动程序
    • 约束因素
    • 机会
    • 任务
  • COVID-19 对全球数位药房市场的影响

第五章市场变量与展望

  • SWOT 分析
    • 实力
    • 弱点
    • 机会
    • 威胁
  • PESTEL 分析
    • 政治局势
    • 经济状况
    • 社会状况
    • 技术情况
    • 环境状况
    • 法律状况
  • 波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的敌对关係
  • 热图分析

第 6 章全球数位药房市场（百万美元）（2019-2030）：按药物类型

  • 非处方产品
    • 非处方药的易用性和便利性推动了市场增长
  • 处方药
    • 由于人口老龄化和随之而来的慢性病增加，对处方药的需求不断增加

第 7 章全球数位药房市场（百万美元）（2019-2030）：按产品分类

  • 药物和治疗
    • 糖尿病护理
    • 心臟护理
    • 肿瘤
  • 维生素和补充剂
    • COVID-19 大流行引发对免疫相关补充剂的需求增加，推动市场增长
  • 个人护理用品
    • 对个人健康和卫生的日益浓厚的兴趣推动了市场增长
  • 其他产品

第 8 章全球数位药房市场（百万美元）（2019-2030）：按平台分类

  • 应用程序 (AAPS)
    • 由于非接触式交付等优势，对 AAPS 的需求不断上升
  • 网站
    • 网站为促进市场增长而提供的促销、折扣和优惠

第 9 章全球数位药房市场（百万美元）（2019-2030 年）：按商业模式分类

  • 俘虏
    • 专属模式的灵活性、可访问性和可负担性——推动市场增长的关键因素
  • 聚合器
    • 与聚合器模式相关的高质量服务推动市场增长
  • 特许经营
    • 药房特许经营数量的增加推动市场增长

第 10 章全球数位药房市场（百万美元）（2019-2030 年）：按地域覆盖

  • 市区
    • 由于互联网在城市地区的快速普及，促进该细分市场的增长
  • 农村地区
    • 政府推动农村地区数位药店需求的举措

第 11 章全球数位药房市场（百万美元）（2019-2030）：按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯王国
    • 阿拉伯联合酋长国
    • 其他中东

第 12 章公司简介

  • Amazon.com Inc.
  • Apex Pharmacy
  • Apollo Pharmacy
  • Cigna
  • Costco Wholesale Corporation
  • CVS Health
  • DocMorris
  • Giant Eagle Inc.
  • GoodRx
  • HealthWarehouse Inc.
  • Hims & Hers Health Inc.
  • Lloyds Pharmacy
  • Netmeds.com
  • NorthWestPharmacy.com
  • Optum Inc.
  • PharmEasy
  • Pharmex Direct Inc.
  • Rexall Pharmacy Group ULC
  • Rite Aid Corp.
  • Ro Pharmacy
  • Rx Outreach
  • Shop-apotheke.com
  • Tata 1mg
  • TELUS
  • The Independent Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Inc.
简介目录
Product Code: PHAR2207

According to SPER Market Research, the Digital Pharmacy Market is estimated to reach USD 334.25 billion by 2030 with a CAGR of 16.8%.

The rising consumer desire for purchasing pharmaceuticals online during and after the COVID-19 pandemic, market consolidation and partnerships, and the rising elderly population all contribute to the sector's growth. During the projected period, an increasing number of violent pharmacies and patients who depend on pharmacists for therapeutic support are anticipated to hinder the growth of this market.

Impact of COVID-19 on the Global Digital Pharmacy Market

Other significant reasons boosting the market growth include the expanding number of internet users, more access to online services, and the increased deployment of e-prescriptions in healthcare services in the aftermath of the COVID-19 epidemic. In March 2020, CVS Health began implementing new strategies to balance the demand for medications used throughout the treatment of both COVID-19 and other chronic conditions. In November 2020, Amazon will start an online pharmacy service in the United States for both generic and prescription pharmaceuticals. Before COVID-19, 70% of families were chronic-first consumers of digital pharmacy because they saw superior value in these affordable and convenient services. Nevertheless, as digital pharmacy proved the need of the hour during the lockdown period, an identical amount of chronic-first and acute-first families were onboarded. Furthermore, the rising demand for over-the-counter (OTC) items such as masks, sanitizers, thermometers, and steamers, among others, is supporting the expansion of the digital pharmacy market. As a result, the rapid use of OTC products will benefit the digital pharmacy sector.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Amazon.com Inc., Apex Pharmacy, Apollo Pharmacy, Cigna, Costco Wholesale Corporation, CVS Health, DocMorris, Giant Eagle Inc., GoodRx, HealthWarehouse Inc., Hims & Hers Health Inc., Lloyds Pharmacy, Netmeds.com, NorthWestPharmacy.com, Optum Inc., PharmEasy, Pharmex Direct Inc., Rexall Pharmacy Group ULC, Rite Aid Corp., Ro Pharmacy, Rx Outreach, Shop-apotheke.com, Tata 1mg, TELUS, The Independent Pharmacy, The Kroger Co., Walgreen Co., Walmart Inc.

Global Digital Pharmacy Market, By Drug Type:

Based on the Drug Type, Global Digital Pharmacy Market is segmented as; Over-The-Counter Products (Ease of use and convenience associated with Over-The-Counter products to drive market growth), Prescription Medicines (Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication).

Global Digital Pharmacy Market, By Product:

Based on the Product, Global Digital Pharmacy Market is segmented as; Medicines and Treatments {Diabetes Care (Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments), Heart Care (Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments), Oncology (Increasing prevalence of cancer is a major factor driving the growth of this market segment, Other medicines & treatments)}, Vitamins and Supplements (Growing demand for immunity-associated supplements in the wake of the COVID-19 pandemic to drive market growth), Personal Care Products (Growing focus on personal health & hygiene to drive market growth), Other Products.

Global Digital Pharmacy Market, By Platform:

Based on the Platform, Global Digital Pharmacy Market is segmented as; Applications (AAPS) (Advantages such as contactless delivery will drive the demand for AAPS), Websites (Promotions, discounts, and offers provided by websites to drive market growth).

Global Digital Pharmacy Market, By Business Model:

Based on the Business Model, Global Digital Pharmacy Market is segmented as; Captive (Flexibility, accessibility, and affordability of captive models-key factors driving market growth), Aggregator (Quality services associated with aggregator models to drive market growth), Franchise (Growing number of pharmacy franchises to drive market growth).

Global Digital Pharmacy Market, By Geographic Coverage:

Based on the Geographic Coverage, Global Digital Pharmacy Market is segmented as; Urban Areas (Rapid internet penetration in urban areas to drive market growth in this segment), Rural Areas (Government initiatives to fuel the demand for digital pharmacies in rural areas).

Global Digital Pharmacy Market, By Region:

North America owns the prime share of this market; the major factors of the market's growth in the region are the increasing incidence of chronic illnesses, the growing amount of medicine prescriptions brought on by the region's rapidly aging population, and the expansion of key market participants in the area.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Digital Pharmacy Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Digital Pharmacy Market, By Drug Type, 2019-2030 (USD Million)

  • 6.1. Over-The-Counter Products
    • 6.1.1. Ease of use and convenience associated with Over-The-Counter products to drive market growth
  • 6.2. Prescription Medicines
    • 6.2.1. Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication

7. Global Digital Pharmacy Market, By Product, 2019-2030 (USD Million)

  • 7.1. Medicines and Treatments
    • 7.1.1. Diabetes Care
      • 7.1.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
    • 7.1.2. Heart Care
      • 7.1.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
    • 7.1.3. Oncology
      • 7.1.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
      • 7.1.3.2 Other medicines & treatments
  • 7.2. Vitamins and Supplements
    • 7.2.1 Growing demand for immunity-associated supplements in the wake of the Covid-19 pandemic to drive market growth
  • 7.3. Personal Care Products
    • 7.3.1 Growing focus on personal health & hygiene to drive market growth
  • 7.4. Other Products

8. Global Digital Pharmacy Market, By Platform, 2019-2030 (USD Million)

  • 8.1. Applications (AAPS)
    • 8.1.1 Advantages such as contactless delivery will drive the demand for AAPS
  • 8.2. Websites
    • 8.2.1 Promotions, discounts, and offers provided by websites to drive market growth

9. Global Digital Pharmacy Market, By Business Model, 2019-2030 (USD Million)

  • 9.1. Captive
    • 9.1.1 Flexibility, accessibility, and affordability of captive models-key factors driving market growth
  • 9.2. Aggregator
    • 9.2.1 Quality services associated with aggregator models to drive market growth
  • 9.3. Franchise
    • 9.3.1 Growing number of pharmacy franchises to drive market growth

10. Global Digital Pharmacy Market, By Geographic Coverage, 2019-2030 (USD Million)

  • 10.1 Urban Areas
    • 10.1.1 Rapid internet penetration in urban areas to drive market growth in this segment
  • 10.2 Rural Areas
    • 10.2.1 Government initiatives to fuel the demand for digital pharmacies in rural areas

11. Global Digital Pharmacy Market, By Region, 2019-2030 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Amazon.com Inc.
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 Apex Pharmacy
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 Apollo Pharmacy
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 Cigna
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 Costco Wholesale Corporation
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 CVS Health
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 DocMorris
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Giant Eagle Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 GoodRx
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 HealthWarehouse Inc.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Hims & Hers Health Inc.
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Lloyds Pharmacy
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 Netmeds.com
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 NorthWestPharmacy.com
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Optum Inc.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 PharmEasy
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Pharmex Direct Inc.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Rexall Pharmacy Group ULC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 Rite Aid Corp.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Ro Pharmacy
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21 Rx Outreach
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22 Shop-apotheke.com
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23 Tata 1mg
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24 TELUS
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25 The Independent Pharmacy
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments
  • 12.26 The Kroger Co.
    • 12.26.1. Company details
    • 12.26.2. Financial outlook
    • 12.26.3. Product summary
    • 12.26.4. Recent developments
  • 12.27 Walgreen Co.
    • 12.27.1. Company details
    • 12.27.2. Financial outlook
    • 12.27.3. Product summary
    • 12.27.4. Recent developments
  • 12.28 Walmart Inc.
    • 12.28.1. Company details
    • 12.28.2. Financial outlook
    • 12.28.3. Product summary
    • 12.28.4. Recent developments